Literature DB >> 10752515

Recent developments in ovarian cancer screening.

U Menon1, I J Jacobs.   

Abstract

There has been growing interest in the possibility of screening for ovarian cancer. This article addresses papers published following a systematic review of all prospective ovarian cancer screening studies since 1998. In the past year, new markers have been reported and previous strategies have been refined. A randomized controlled trial of ovarian cancer screening has shown a survival benefit in women who developed ovarian cancer in the screened group. Although the results do not justify ovarian cancer screening in the general population, the data support the need for a larger randomized trial powered to assess the impact of screening on mortality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752515     DOI: 10.1097/00001703-200002000-00007

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  17 in total

1.  Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.

Authors:  Liuxia Li; Kaijuan Wang; Liping Dai; Peng Wang; Xuan-Xian Peng; Jian-Ying Zhang
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

2.  New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Renyong Guo; Chunqin Pan; Jianmin Shen; Chibo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-21       Impact factor: 4.553

Review 3.  Imaging applications of nanotechnology in cancer.

Authors:  U Ayanthi Gunasekera; Quentin A Pankhurst; Michael Douek
Journal:  Target Oncol       Date:  2009-10-30       Impact factor: 4.493

4.  Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Authors:  Feng Qiu; Hong-Ying Liu; Zhen-Nan Dong; Ying-Ji Feng; X-J Zhang; Ya-Ping Tian
Journal:  Am J Biomed Sci       Date:  2009-01-01

Review 5.  Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.

Authors:  Hiroshi Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

6.  Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells.

Authors:  Wei Xiang; Pauline Wimberger; Torsten Dreier; Joachim Diebold; Doris Mayr; Patrick A Baeuerle; Rainer Kimmig
Journal:  J Cancer Res Clin Oncol       Date:  2003-06-18       Impact factor: 4.553

7.  Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer.

Authors:  Jongyun Hwang; Sunghun Na; Hyangah Lee; Dongheon Lee
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

8.  Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.

Authors:  Katherine R Kozak; Malaika W Amneus; Suzanne M Pusey; Feng Su; Mui N Luong; Sam A Luong; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

9.  Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers.

Authors:  Yong-Wan Kim; Su Mi Bae; Hyunsun Lim; Yoon Ji Kim; Woong Shick Ahn
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

10.  Serum biomarkers identification by mass spectrometry in high-mortality tumors.

Authors:  Alessandra Tessitore; Agata Gaggiano; Germana Cicciarelli; Daniela Verzella; Daria Capece; Mariafausta Fischietti; Francesca Zazzeroni; Edoardo Alesse
Journal:  Int J Proteomics       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.